UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial

The lancet. Diabetes & endocrinology, 2016-11, Vol.4 (11), p.893-902

2016

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups

Journal of gastroenterology and hepatology, 2013-04, Vol.28 (4), p.664-670

2013

Volltextzugriff (PDF)

Indole-3-carboxyaldehyde does not reverse the intestinal effects of fiber-free diet in mice

Frontiers in endocrinology (Lausanne), 2024, Vol.15, p.1362711-1362711

2024

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease

Pancreas, 2010-11, Vol.39 (8), p.1185-1190

2010

Volltextzugriff (PDF)

L-valine is a powerful stimulator of GLP-1 secretion in rodents and stimulates secretion through ATP-sensitive potassium channels and voltage-gated calcium channels

Nutrition & diabetes, 2024-06, Vol.14 (1), p.43-11

2024

Volltextzugriff (PDF)

Smoking Is Related to Pancreatic Fibrosis in Humans

The American journal of gastroenterology, 2011-06, Vol.106 (6), p.1161-1166

2011

Volltextzugriff (PDF)

Alpha-cyclodextrin increases glucagon-like peptide-1 secretion in multiple models and improves metabolic status in mice

Food chemistry, 2024-12, Vol.460 (Pt 3), p.140759, Article 140759

2024

Volltextzugriff (PDF)

Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis

Annals of epidemiology, 2013-07, Vol.23 (7), p.415-421

2013

Volltextzugriff (PDF)

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

Diabetologia, 2016-12, Vol.59 (12), p.2588-2593

2016

Volltextzugriff (PDF)

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Diabetes care, 2016-11, Vol.39 (11), p.2042-2050

2016

Volltextzugriff (PDF)

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Diabetologia, 2016-07, Vol.59 (7), p.1412-1421

2016

Volltextzugriff (PDF)

Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial

Diabetes, obesity & metabolism, 2017-12, Vol.19 (12), p.1669-1680

2017

Volltextzugriff (PDF)

Renal sinus fat and renal hemodynamics: a cross-sectional analysis

Magma (New York, N.Y.), 2020-02, Vol.33 (1), p.73-80

2020

Volltextzugriff (PDF)

Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial

European journal of endocrinology, 2017-01, Vol.176 (1), p.77-86

2017

Volltextzugriff (PDF)

Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males

British journal of clinical pharmacology, 2016-04, Vol.81 (4), p.613-620

2016

Volltextzugriff (PDF)

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The New England journal of medicine, 2016-06, Vol.374 (23), p.2290-2295

2016

Volltextzugriff (PDF)

Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial

Diabetes care, 2020-11, Vol.43 (11), p.2889-2893

2020

Volltextzugriff (PDF)

Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients

Diabetes, obesity & metabolism, 2016-12, Vol.18 (12), p.1217-1225

2016

Volltextzugriff (PDF)

Effect of immediate and prolonged GLP‐1 receptor agonist administration on uric acid and kidney clearance: Post‐hoc analyses of four clinical trials

Diabetes, obesity & metabolism, 2018-05, Vol.20 (5), p.1235-1245

2018

Volltextzugriff (PDF)

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The New England journal of medicine, 2016-06, Vol.374 (23), p.2291

2016

Volltextzugriff (PDF)

GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

Arteriosclerosis, thrombosis, and vascular biology, 2016-10, Vol.36 (10), p.2125-2132

2016

Volltextzugriff (PDF)

Understanding EMPA-REG OUTCOME

The lancet. Diabetes & endocrinology, 2015-12, Vol.3 (12), p.928-929

2015

Volltextzugriff (PDF)

Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus Patients

Hypertension (Dallas, Tex. 1979), 2018-08, Vol.72 (2), p.314-322

2018

Volltextzugriff (PDF)

Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity

Journal of diabetes and its complications, 2022-04, Vol.36 (4), p.108166-108166, Article 108166

2022

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(119)

Sprache

Englisch
(119)

Erscheinungsjahr

n.n

Thema

Humans
(112)
Female
(108)
Science & Technology
(106)
Life Sciences & Biomedicine
(101)
Middle Aged
(66)
Adult
(65)
Aged
(47)
Biological And Medical Sciences
(35)
Medical Sciences
(34)
Treatment Outcome
(26)
Endocrinology & Metabolism
(18)
Diabetes Mellitus, Type 2 - Drug Therapy
(17)
Psychology
(17)
Social Sciences
(17)
Double-Blind Method
(16)
Psychology, Clinical
(16)
Infectious Diseases
(15)
Adolescent
(14)
Diabetes
(14)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial

Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups

Indole-3-carboxyaldehyde does not reverse the intestinal effects of fiber-free diet in mice

Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease

L-valine is a powerful stimulator of GLP-1 secretion in rodents and stimulates secretion through ATP-sensitive potassium channels and voltage-gated calcium channels

Smoking Is Related to Pancreatic Fibrosis in Humans

The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

Alpha-cyclodextrin increases glucagon-like peptide-1 secretion in multiple models and improves metabolic status in mice

Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial

Renal sinus fat and renal hemodynamics: a cross-sectional analysis

Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial

Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial

Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients

Effect of immediate and prolonged GLP‐1 receptor agonist administration on uric acid and kidney clearance: Post‐hoc analyses of four clinical trials

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

Understanding EMPA-REG OUTCOME

Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus Patients

Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity

Aktive Filter

Suchergebnisse filtern